Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis

NCT04017936 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT04017936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04017936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis
Lead sponsor
Virginia Commonwealth University
Phase
Phase 2
Overall status
Completed
Start date
October 23, 2020
Completion date
June 30, 2024
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac sarcoidosis